163: LungTech stereotactic body radiotherapy (SBRT) of inoperable centrally located NSCLC: a phase II study in preparation for a randomised phase III trial.
Affiliation
University of Manchester, Division of Molecular and Clinical Cancer Science, Faculty of Biology, Medicine and Health, ManchesterIssue Date
2017-01
Metadata
Show full item recordCitation
163: LungTech stereotactic body radiotherapy (SBRT) of inoperable centrally located NSCLC: a phase II study in preparation for a randomised phase III trial. 2017, 103(suppl 1):S74-S75 Lung CancerJournal
Lung CancerDOI
10.1016/S0169-5002(17)30213-1Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0169500217302131Type
Meetings and ProceedingsLanguage
enISSN
01695002ae974a485f413a2113503eed53cd6c53
10.1016/S0169-5002(17)30213-1